Upsher-Smith Launches Generic Clomipramine

Upsher-Smith Laboratories, Inc. has announced the U.S. launch of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and 75 mg, the generic equivalent to Mallinckrodt Pharmaceuticals' Anafranil^® (clomipramine hydrochloride) Capsules USP.

The clomipramine hydrochloride capsules market had U.S. sales of approximately $172 million for the 12 months ending December 2016, according to IMS Health.

"Upsher-Smith has long been recognized within the pharmaceutical industry as a trusted name in generics," said Rusty Field, President, Upsher-Smith. "This is an exciting time for the Company. Upsher-Smith currently has more active ANDA programs in development than at any point in its history and is committed to expanding its portfolio of quality, high-value generic products through both internal development and strategic partnerships."

Product Information